Glycosylation-dependent cell adhesion molecule 1 (GlyCAM
Introduction Glycosylation-dependent cell adhesion molecule 1 (GlyCAM 1 )1 is a recently described sulfated glycoprotein that appears to peripheral lymph nodes.
mediate leukocyte-endothelial cell adhesion by presenting carbohydrate ligands to the lectin domain of L selectin (1) (2) (3) (4) (5) . GlyCAM I appears to be a mucinlike glycoprotein, since 70% of its native molecular weight is contributed by carbohydrates that are found in two serine/threonine rich 0-linked domains (5) . The tissue specific expression of this mucin on the lumenal surface of the high endothelial venules (HEV) of peripheral lymph nodes (PLN) and mesenteric lymph nodes is consistent with a role for GlyCAM 1 in the regional trafficking of lymphocytes to these lymphoid organs. In addition to the expression of GlyCAM 1 in these lymphoid locations, mRNA for this glycoprotein has been demonstrated in lung, although the anatomic localization of lung GlyCAM 1 has not been described. The interaction between GlyCAM 1 and L selectin is dependent upon the O-linked carbohydrate side chains that are presented by the mucin to the leukocyte selectin. These carbohydrates have been shown to contain a sialic acid component that is critical for the recognition ofthese carbohydrate ligands by the L selectin lectin domain (2) . In addition, recent data have demonstrated that the sulfate modification of the carbohydrates attached to GlyCAM 1 is also required for the adhesive recognition of this glycoprotein by L selectin (3, 6) . Finally, the expression of GlyCAM 1 mRNA and protein appear to be regulated by afferent lymphatic flow, since deafferentiation of peripheral lymph nodes results in a loss ofexpression of these components as well as in a profound decrease in the trafficking of lymphocytes to these treated sites (7, 8, Mebius, R., L. Lasky, and S. Watson, unpublished observations). This result suggests that the tissue-specific expression ofGlyCAM 1 in the PLN lymphoid compartment is defined by a potentially unique regulatory mechanism.
Mucins other than GlyCAM I are expressed in a number of organs and fulfill a variety of functions. For example, mucins that are expressed in the gastrointestinal and respiratory tracts and the vagina function as lubricants and to protect the epithelium (9) (10) (11) (12) (13) (14) . Another mucinlike molecule, ZP3, is expressed by mammalian eggs and appears to function as a sperm receptor ( 15, 16 ). Yet another interesting and important site of mucin biosynthesis is in milk ( 17, 18) . Milk has a number of functions in addition to nutrition, and one of the most important ones is to protect the offspring from gut and respiratory pathogens (19) (20) (21) . This protection is, in part, elicited by secretory IgA antibodies (22) , but an additional component of this protective response appears to be derived from milk mucins (19) (20) (21) ). Work from Yolken and colleagues has demonstrated that the milk mucin complex, a high molecular weight aggregate of several mucinlike glycoproteins that is associated with the milk fat globule, has antiviral activity against rotaviruses, which are gut pathogens that elicit diarrhea in infants (20, 21 ) . The mechanism for this antiviral activity is hypothesized to be competitive inhibition of viral binding to its cellular receptor, since the virus can be demonstrated to bind directly to the partially purified milk mucin complex. The antiviral effect appears to be due to carbohydrate side chains on the milk mucins, since removal of the sialic acid from these mucins by enzymatic or chemical treatment appears to eliminate the antiviral effect (20, 21) . Other investigators have demonstrated that a similar high molecular weight mucin complex from milk also inhibits the replication of respiratory syncitial virus ( 19) . These data are consistent with the hypothesis that some mucins in milk may function as naturally occurring antibiotics that prevent respiratory and/or gastrointestinal pathogenesis in immunologically naive offspring.
To examine if GlyCAM 1 has the potential to function as a scaffold for presentation of carbohydrates for other functions in tissues such as the mammary gland, we have examined the expression ofthis mucin in murine milk. Here we describe data demonstrating that a form of GlyCAM 1 that does not bind to L selectin is expressed as a hormonally induced protein in the whey fraction of murine milk, and we offer some speculations as to the possible functional significance of the regulated expression of this mucin.
Methods
RNA analysis. Total RNA from either mammary tissues at various times during pregnancy and lactation or other organs was purified as previously described (5) . Northern blot analysis using equivalent amounts of total RNA from each tissue was performed using a Gly-CAM I cDNA that was 32P-labeled using the random priming method. Filters were washed and exposed to x-ray film as previously described (5, 23) .
In situ hybridization analysis. Mammary tissues from lactating or virgin female mice were sectioned and prepared for in situ hybridization as previously described for PLN tissue. Antisense and sense probes were produced using the previously described GlyCAM I subclone in pSKII (Stratagene Inc., La Jolla, CA). Sections were processed and exposed as previously described (5, 24) .
Immunohistochemistry. Mammary tissues from lactating and virgin mice were dissected out and immersed in buffered 4% paraformaldehyde. The tissues were hydrated with a series of ascending ethanol steps and substituted with xylol and embedded in paraffin. 3-Mm thick paraffin sections were cut and mounted on albumen-coated slides. Deparaffinized sections were rinsed with PBS and then incubated with PBS/5% normal goat serum. The sections were then stained with the previously described anti-GlyCAM 1 peptide antisera for 1 h. Sections were washed and then incubated with biotin anti-rabbit IgG for 30 min. The sections were washed and then incubated with horseradish peroxidase-conjugated streptavidin and diaminobenzidine substrate. The sections were finally counterstained with hematoxylin or methyl green and photographed.
Western blot analysis. The whey fraction of murine milk was isolated by centrifugation of either frozen or fresh murine milk (21 ) , and this fraction was boiled for 5 min and centrifuged to remove denatured proteins. Various amounts of the boiled whey fraction were run on 4-20% acrylamide gradient gels after boiling in SDS-mercaptoethanol and transferred to a ProBlot (Applied Biosystems, Inc., Foster City, CA) membrane electrophoretically (25) . The blots were incubated with a 2% solution of bovine skim milk, and then they were reacted with a 1:1,000 dilution of antipeptide antiserum overnight. The blots were washed and then incubated with protein G gold reagent until a signal could be visualized, after which the blots were enhanced with silver. A GlyCAM 1 IgG fusion protein was produced in transfected 293 cells as previously described for L selectin (26) (2, 3) . Solubilized proteins were precipitated with either an L selectin IgG (21 ) chimera or with antipeptide antisera as previously described (2, 3, 5) . The precipitated proteins were run on 4-20% acrylamide gradient gels, treated with Amplity (Amersham, Inc., Amersham, UK), and autoradiographed.
Results
Expression ofGlyCAM I mRNA duringpregnancy. During the DNA sequence analysis of the genomic region that encodes murine GlyCAM 1 (27) , a search of the GenBank revealed that this region of the murine genome had been previously isolated and was shown to encode an mRNA that was expressed in mammary glands during pregnancy and lactation but not in virgin mammary glands (28, 29) . To determine if this mammary gland mRNA encoded GlyCAM 1, we analyzed the expression of mRNA encoding this mucin during pregnancy and lactation using the isolated GlyCAM 1 cDNA. As can be seen in Fig. 1 glands also increases, although the relative degree of enhanced expression is only a fewfold and is, therefore, far less than that seen for lactating versus virgin mammary glands (> 100-fold). Panel C illustrates the time course of induction of the expression of GlyCAM 1 mRNA during pregnancy. As has been found for a number ofother milk proteins that are regulated by levels of progesterone, prolactin, and insulin, the expression of GlyCAM 1 mRNA begins on day 10 of pregnancy, reaches a peak on day 15, and begins to fall slightly until the completion of gestation. These data clearly demonstrate that GlyCAM 1 mRNA is expressed in murine mammary glands in a manner that appears identical to that previously described for milk proteins that are hormonally regulated during pregnancy and lactation.
In situ hybridization analysis. Although the expression of GlyCAM 1 during pregnancy and lactation appeared to mimic that seen for the milk proteins that are produced by the mammary secretory epithelial cells, it was possible that the elevated expression ofthis mucin was in a mammary vascular site analogous to the HEV. Such vascular expression of GlyCAM 1 during lactation might be expected if this L selectin ligand was involved in the trafficking of, for example, IgA-secreting B cells to the mammary glands (22) . To (Fig. 4) . These ment for ligand recognition by L selectin (3, 26) , and the prediction was, therefore, that the mammary form of GlyCAM 1 should not react with the previously described L selectin IgG chimera. Fig. 5 shows that, while the HEV form of the mucin, when labeled with [ 3H ]serine and threonine, reacted in a calcium-dependent (i.e., carbohydrate-directed) manner with the L selectin IgG chimera (2, 3, 5) , the 3H-labeled mammary form of GlyCAM 1 could not react with this IgG chimera. These results support the previous data implicating the requirement for sulfate-modified carbohydrates in L selectin ligand recognition of GlyCAM 1 (3) and suggest that the mammary form of the mucin contains different posttranslational modifications than the HEV form. Finally, these data do not rule out the possibility that other modifications, such as the presence or absence of sialic acid or fucose in the appropriate linkages (2), may also differ between the milk and PLN forms of GlyCAM 1.
Discussion
The data in this report demonstrate that GlyCAM 1, a mucinlike glycoprotein that was previously demonstrated to be a tissue-specific adhesion ligand for L selectin, is also expressed during pregnancy and lactation in milk. The data also demonstrate that the form of GlyCAM 1 that is expressed in milk appears to lack the sulfate modification that is found in the endothelial form, and that this mammary form is unable function as a ligand for L selectin. These results are consistent with the possibility that the mammary form of GlyCAM 1 has a function other than cell adhesion, a hypothesis that suggests that the GlyCAM 1 polypeptide may be a scaffold that presents diverse carbohydrates for different tissue-specific functions.
Previous work investigating the expression ofGlyCAM 1 in mammary glands suggested that the regulation of the expression of this protein was under hormonal control during pregnancy (28, 29) . A number of observations in this paper support this supposition. For example, previous data have indicated a requirement for continued suckling by pups for the expression ofmilk proteins regulated by prolactin, insulin, and steroids (30) (31) (32) (33) , and we found here that removal ofpups from lactating mothers resulted in the downregulation ofthe expression of the mRNA for GlyCAM 1. In addition, we found that the mRNA for GlyCAM 1 is induced during pregnancy with kinetics that mimic those seen with other milk proteins (31, 32) . These data suggest that the mammary expression of Gly-CAM 1 is under hormonal control, and they are supported by the sequence analysis of the GlyCAM 1 genomic fragment (27) (28) (29) . This analysis revealed several potential glucocorticoid receptor binding elements and a number of sequences potentially capable of binding the mammary gland transcription factor (27, 34) . The mammary gland transcription factor has been shown to be regulated by hormones during pregnancy, and its expression mirrors the expression ofGlyCAM 1 illustrated here (34) . The expression and sequence data are, therefore, consistent with the regulation of GlyCAM 1 by elevated levels of prolactin, insulin, and steroids during pregnancy, and with the regulation of the levels of these hormones by neuroendocrine stimulation of the mammary gland by the sucking pups (33) . These data therefore provide an interesting (9) (10) (11) (12) (13) (14) . An argument against this hypothesis is that it might be expected that large quantities of a mucin might be required for this protective/lubrication function, but the Western blot analysis shown above suggests that relatively low levels ( -micrograms per ml) of GlyCAM 1 glycoprotein appear to be present in milk. Mucins have also been shown to function as adhesive ligands for sperm binding to mammalian eggs ( 15, 16 ), but it is unlikely that milk GlyCAM 1 plays any such adhesive function. An alternative hypothesis is that GlyCAM 1 may be another mucin whose role is to inhibit the replication of pathogenic organisms in the respiratory and gastrointestinal tracts. Previously published data suggest that the mucins in the high molecular weight mucin complex associated with the milk fat globules have antirotaviral activity at relatively low concentrations ( -0.1 Iig/ml) (21 ) . This inhibition appears to be mediated by carbohydrate side chains, particularly sialic acids, that are attached to these mucins and the mechanism ofinhibition appears to be due to competitive blocking of viral binding to the cell surface (21 ) . The mucinlike structure ofGlyCAM 1 (35) (36) (37) (38) is consistent with the possibility that it too may function as a naturally occurring antiinfection agent, and we are currently attempting to purify sufficient quantities of this glycoprotein from milk to analyze this prospect.
In addition to differences in sulfation, another apparent major difference between HEV GlyCAM 1 and mammary GlyCAM 1 is in their relative degrees of cell association. HEV GlyCAM 1 appears to be associated lumenally with HEVs, a result that is expected in view of its presumed role as an adhesion molecule (1-3, 5) . The immunohistochemical data described here suggest that mammary GlyCAM 1 is readily secreted into the lumenal milk, and the direct demonstration of this mucin in milk supports this result. Interestingly, low levels of sulfated, active GlyCAM 1 can also be demonstrated to be shed into the circulation in vivo (39) . The physiological reasons for this vascular shedding are not clear, but one possibility is that GlyCAM 1 must be weakly associated with the HEV surface to allow for ready extravasation of the recirculating lymphocyte into the lymph node. Because GlyCAM 1 does not have a transmembrane domain or phosphatidyl-inositol-type linkage, the mechanism by which HEV GlyCAM 1 is bound to the cell surface can only be speculated upon. Various possibilities include association with a transmembrane protein or peripheral insertion into the membrane through the COOH-terminal amphipathic helix (40, 41). The results reported here may be interpreted to suggest that, since GlyCAM 1 was forced to evolve for dual functions in the vasculature and in milk, a creative mechanism for HEV surface association was derived to allow the mammary form ofthe protein to be easily secreted. 
